June 27, 2026
New Altesa BioSciences Data: Vapendavir Demonstrates Anti-Viral Activity Against All Three Rhinovirus Species
B In vivo, in vitro, and in silico data indicate vapendavir, the only clinical stage, direct-acting antiviral for rhinovirus, works against Rhinovirus C (RV-C) PRAGUE, May 12, 2026…
